PROM1 and neoplasm: Immunostaining of MMTV tumor samples for CD133 revealed that nearly 20% of the cell population possessed stem cell character in control tumors; however, the number was reduced to approximately 10% upon Sac-1004 treatment (Figure 7F,G).